Who is sponsoring NCT05103865?

NCT05103865 is sponsored by Miguel Monfort Montolio.

What drugs are being tested in NCT05103865?

Interventions in NCT05103865: Animal-assisted therapy (AAT), usual treatment.

What condition does NCT05103865 study?

NCT05103865 studies Diagnosis, Dual (Psychiatry).

Is NCT05103865 still recruiting?

NCT05103865 is currently completed. Last updated 2 November 2021.

Last reviewed 2021-11-02 · How we verify

NCT05103865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions

Completed NA Last updated 2 November 2021

What this trial tests

NA trial testing Animal-assisted therapy (AAT) in Diagnosis, Dual (Psychiatry) in 160 participants. Completed in 10 September 2019.

Timeline

3 November 2015

Primary endpoint
20 May 2019

10 September 2019

Quick facts

Lead sponsor	Miguel Monfort Montolio
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	160
Start date	3 November 2015
Primary completion	20 May 2019
Estimated completion	10 September 2019

Drugs / interventions tested

Animal-assisted therapy (AAT)
usual treatment — full drug profile →

Conditions studied

Diagnosis, Dual (Psychiatry) — all drugs for Diagnosis, Dual (Psychiatry) →

Sponsor

Miguel Monfort Montolio

Who can join

18 and older, any sex, with Diagnosis, Dual (Psychiatry). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the efectiveness of an AAT program in patients diagnosed with substance abuse disorder and associated mental disorders (dual pathology).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Efficacy of Animal-Assisted Therapy in Patients with Dual Diagnosis: Schizophrenia and Addiction.
Monfort M, Benito A, Haro G, Fuertes-Saiz A, et al · · 2022 · cited 4× · PMID 35682281 · DOI 10.3390/ijerph19116695

Verify or expand the search:

Other Miguel Monfort Montolio trials

Trials by the same sponsor.

NCT05115266 — Efficacy of Animal-assisted Therapy in Patients With Borderline Personality Disorder and Addictions. · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05103865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Miguel Monfort Montolio
Last refreshed: 2 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05103865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing